Aligning HCP Interactions on a Global Level

Aligning HCP Interactions on a Global Level

At the Pharma Forum 2014, held in March in Orlando, globalization was one of the main themes. Specifically, how can pharma and medical device companies manage their interactions with healthcare professionals in multiple countries, each of which has its own rules and regulations around pharmaceutical company/HCP interactions. Here's how one company is doing it.

Say your company is one of the world’s largest pharma or biotech firms with almost 100 products being marketed in 60 countries and close to 30,000 employees. You—and others in your company—are likely planning meetings for healthcare professionals spanning the globe, but there is no centralized process controlling all those HCP interactions and ensuring all the rules and regulations are being followed.

The result? At best, a lot of confusion, redundancy, and wasted time. At worst?

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.